Citation Impact
Citing Papers
Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology
2008
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
2011 StandoutScience
Tough adhesives for diverse wet surfaces
2017 StandoutScience
A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema
2011
Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling
2009
Mechanisms of Thrombus Formation
2008 Standout
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
2005 StandoutNobel
Asymmetric total synthesis of sperabillins B and D via lithium amide conjugate addition
2004
Diabetic retinopathy
2010 Standout
Designing hydrogel adhesives for corneal wound repair
2007
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
2011 Standout
Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
2008
Age-Related Macular Degeneration
2008 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
The biology of VEGF and its receptors
2003 Standout
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
1988 StandoutNature
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Lymphangiogenesis in development and human disease
2005 StandoutNature
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE
2005
Diabetic Retinopathy
2012 Standout
Diabetic retinopathy and systemic vascular complications
2007
The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine
2009
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004 Standout
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
2006 Standout
Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product
1991 StandoutNobel
Aptamers as tools for target validation
2005
O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress
2004
Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor.
1992
Chemical Approaches To Perturb, Profile, and Perceive Glycans
2009 StandoutNobel
The biology of vascular endothelial growth factors
2005
VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
1999
Verteporfin and Intravitreal Triamcinolone Acetonide Combination Therapy for Occult Choroidal Neovascularization in Age-Related Macular Degeneration
2006
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Vascular endothelial growth factor and diabetic complications
2008
O-GlcNAc modification of nucleocytoplasmic proteins and diabetes
2005
Genetic Alterations during Colorectal-Tumor Development
1988 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Pegaptanib for Neovascular Age-Related Macular Degeneration
2004 Standout
O-GlcNAc cycling: How a single sugar post-translational modification is changing the Way We think about signaling networks
2005
Vascular Growth in Ischemic Limbs: A Review of Mechanisms and Possible Therapeutic Stimulation
2008
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration
2005
Regulation of angiogenesis by tissue factor cytoplasmic domain signaling
2004
Angiogenesis as a therapeutic target
2005 StandoutNature
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
2005
Metabolic cross-talk allows labeling of O-linked β- N -acetylglucosamine-modified proteins via the N -acetylgalactosamine salvage pathway
2011 StandoutNobel
Functional Nucleic Acid Sensors
2009 Standout
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema
2005
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
1987 StandoutScience
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
2011
Hydroamination: Direct Addition of Amines to Alkenes and Alkynes
2008 Standout
VEGF164(165)as the Pathological Isoform: Differential Leukocyte and Endothelial Responses through VEGFR1 and VEGFR2
2004
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Microvascular patterning is controlled by fine-tuning the Akt signal
2004
Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells
2004
Retinoblastoma: Clues to Human Oncogenesis
1984 Science
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
2004
Dendritic macromers for hydrogel formation: Tailored materials for ophthalmic, orthopedic, and biotech applications
2007
Photoacoustic Tomography: In Vivo Imaging from Organelles to Organs
2012 StandoutScience
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy
2007
Nanoparticle-Aptamer Bioconjugates
2004
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Potential Role of Microglia in Retinal Blood Vessel Formation
2006
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Location of the retinoblastoma susceptibility gene(s) and the human esterase D locus.
1984
VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting
2011
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
1986 StandoutNature
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF 165
2005
Isolation and Synthesis of Biologically Active Carbazole Alkaloids
2002 Standout
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
1989 StandoutScience
The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product
1989 StandoutScience
Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners
2012 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction
2016 StandoutNobel
Works of Tetsuo Hida being referenced
Chemistry and Anti-tumor Activity of Sperabillin Polymers.
1993
Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease
2003
RETINAL TOXICITY OF CYANOACRYLATE TISSUE ADHESIVE IN THE RABBIT
1988
Elevated Expression of O-GlcNAc–Modified Proteins and O-GlcNAc Transferase in Corneas of Diabetic Goto-Kakizaki Rats
2003
Tumor-promoting phorbol esters induce angiogenesis in vivo
1988
Experimental and Clinical Observations of the Intraocular Toxicity of Commercial Corticosteroid Preparations
1986
Possible inactivation of part of chromosome 13 due to 13qXp translocation associated with retinoblastoma
1982
VEGF164Is Proinflammatory in the Diabetic Retina
2003
VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization
2003
Bilateral Retinoblastoma with a 13qXp Translocation
1980